Effect of CVP and IOH on AKI and AKD

January 23, 2022 updated by: HONG LIANG, Nanjing First Hospital, Nanjing Medical University

Venous Congestion Rather Than Intraoperative Hypotension is Associated With Acute Adverse Kidney Events After Cardiac Surgery

This study was aimed to explore the effect of intraoperative venous congestion and intraoperative hypotension (IOH) on acute adverse kidney events, defined as acute kidney injury (AKI) and acute kidney disease (AKD), after cardiac surgery

Study Overview

Detailed Description

Venous congestion and IOH were primary exposures and quantified as area under the curve (AUC) of central venous pressure ≥12, 16 or 20 mmHg or mean arterial pressure ≤55, 65, 75 mmHg. The primary outcome was AKI or AKD defined as renal dysfunction persisting > 7 days after surgery. Multivariable logistic regression and Cox proportional hazard models were used to determine the association between intraoperative venous congestion/hypotension and postoperative acute adverse kidney events, respectively, adjusted for relevant confounding factors and multiple comparisons.

Study Type

Observational

Enrollment (Actual)

5127

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Jiangsu
      • Nanjing, Jiangsu, China, 210006
        • Nanjing First Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 86 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All adults undergoing cardiac surgery between 2016 and 2020 (data analysed in 2021) using electronic health records collected from the Nanjing First Hospital.

Description

Inclusion Criteria:

  • Patients aged 18 years and older,
  • Patients underwent cardiac surgery (coronary artery bypass grafting, heart valve surgery, heart transplant or surgical excision of intracardiac myxoma)
  • Patients receiving invasive intraoperative BP monitoring during surgery
  • Patients underwent cardiopulmonary bypass (CPB) during surgery

Exclusion Criteria:

  • Pre-existing renal insufficiency defined by presence of abnormal preoperative serum creatinine ≥ 133 μmol/L and/or preoperative diagnosis of renal insufficiency within 6 months'preoperative period.
  • Patients with preoperative dialysis dependence within 60 days before the index surgical procedure,
  • Surgical duration less than 30 minutes
  • Surgery on the aorta
  • Insufficient hemodynamic and laboratory data for outcomes and/or exposure ascertainment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
CVP ≥ 12
central venous pressure ≥12 mmHg
Venous congestion exposures were quantified as area under the curve (AUC) of central venous pressure ≥12, 16 or 20 mmHg
CVP ≥ 16
central venous pressure ≥16 mmHg
Venous congestion exposures were quantified as area under the curve (AUC) of central venous pressure ≥12, 16 or 20 mmHg
CVP ≥ 20
central venous pressure ≥20 mmHg
Venous congestion exposures were quantified as area under the curve (AUC) of central venous pressure ≥12, 16 or 20 mmHg
MAP ≤ 55 mmHg
mean arterial pressure ≤55 mmHg
Introperation hypotension exposures were quantified as area under the curve (AUC) of mean arterial pressure ≤55, 65, 75 mmHg
MAP ≤ 65 mmHg
mean arterial pressure ≤65 mmHg
Introperation hypotension exposures were quantified as area under the curve (AUC) of mean arterial pressure ≤55, 65, 75 mmHg
MAP ≤ 75 mmHg
mean arterial pressure ≤75 mmHg
Introperation hypotension exposures were quantified as area under the curve (AUC) of mean arterial pressure ≤55, 65, 75 mmHg

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
CSA-AKI
Time Frame: 7 days post operation
Cardiovascular surgery associated acute kidney injury. AKI was defined using the Kidney Disease: Improving Global Outcome (KDIGO) Clinical Practice Guideline for Acute Kidney Injury as an absolute increase in serum creatinine of ≥ 26 μmol/L within 48 hours or an increase in serum creatinine beyond 1.5 times the baseline value within 7 days
7 days post operation
AKD
Time Frame: 8 to 90 days post operation
Acute Kidney Disease, which was defined according to the criteria recommended by the Acute Disease Quality Initiative (ADQI) workgroup.4 AKI was quantified within the 7 days' postoperative period, while AKD was defined as serum creatinine value elevated to 1.5 times the baseline value between 8- and 90-day post-operation period.
8 to 90 days post operation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of AKD of stage 2 and above
Time Frame: 8 to 90 days post operation
incidence of AKD of stage 2 and above, defined as increase in serum creatinine beyond 2.0 times the baseline value between 8- and 90-day post-operation period.
8 to 90 days post operation
RRT initiation
Time Frame: from the end of operation to the discharge from hospital, up to 90 days.
renal replacement theray (RRT) initiation
from the end of operation to the discharge from hospital, up to 90 days.
value of eGFR
Time Frame: 7 days after operation
postoperative estimated glomerular filtration rate (eGFR), which was calculated by MDRD Equation.
7 days after operation
inpatient mortality
Time Frame: 30 days after inhospital
mortality during hospital stay
30 days after inhospital
ICU length of stay
Time Frame: from the end of operation to the discharge from ICU, up to 90 days.
days stay in ICU
from the end of operation to the discharge from ICU, up to 90 days.
length of hospital stay
Time Frame: from the end of operation to the discharge from hospital, up to 90 days.
days stay in hospital
from the end of operation to the discharge from hospital, up to 90 days.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lihai Chen, PhD, chenlihai1983@163.com

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2016

Primary Completion (Actual)

June 30, 2021

Study Completion (Actual)

August 1, 2021

Study Registration Dates

First Submitted

December 26, 2021

First Submitted That Met QC Criteria

January 23, 2022

First Posted (Actual)

February 3, 2022

Study Record Updates

Last Update Posted (Actual)

February 3, 2022

Last Update Submitted That Met QC Criteria

January 23, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Kidney Injury

Clinical Trials on Venous congestion

Subscribe